Report of a semi-branched stent-graft to treat a type 1a endoleak after failed EVAR.

Autor: Yazar O; Department of Vascular Surgery, Zuyderland Medical Center, Heerlen, The Netherlands., Wong C; Department of Vascular Surgery, Zuyderland Medical Center, Heerlen, The Netherlands., Salemans PB; Department of Vascular Surgery, Zuyderland Medical Center, Heerlen, The Netherlands., van Wely C; Department of Vascular Surgery, Zuyderland Medical Center, Heerlen, The Netherlands., Nouwens R; Procurement Department, Zuyderland Medical Center, Heerlen, The Netherlands., van Grinsven B; Department of Sensor Engineering, Faculty of Science and Engineering, Maastricht University, Maastricht, The Netherlands., Bouwman LH; Department of Vascular Surgery, Zuyderland Medical Center, Heerlen, The Netherlands. l.bouwman@zuyderland.nl.; Department of Clinical Engineering, Faculty of Science and Engineering, Maastricht University, Maastricht, The Netherlands. l.bouwman@zuyderland.nl.

Publikováno v: CVIR endovascular [CVIR Endovasc] 2024 Apr 20; Vol. 7 (1), pp. 38. Date of Electronic Publication: 2024 Apr 20.

Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combination.

Autor: Koopman G; Department of Virology, Biomedical Primate Research Center (BPRC), 2288 GH Rijswijk, The Netherlands., Mortier D; Department of Virology, Biomedical Primate Research Center (BPRC), 2288 GH Rijswijk, The Netherlands., Hofman S; Department of Virology, Biomedical Primate Research Center (BPRC), 2288 GH Rijswijk, The Netherlands., Mathy N; GlaxoSmithKline Biologicals, Rixensart, Belgium., Koutsoukos M; GlaxoSmithKline Biologicals, Rixensart, Belgium., Ertl P; GlaxoSmithKline Biopharmaceuticals CEDD Biology, Stevenage, UK., Overend P; GlaxoSmithKline Biopharmaceuticals CEDD Biology, Stevenage, UK., van Wely C; GlaxoSmithKline Biopharmaceuticals CEDD Biology, Stevenage, UK., Thomsen LL; GlaxoSmithKline Biopharmaceuticals CEDD Biology, Stevenage, UK., Wahren B; Swedish Institute for Infectious Disease Control, Karolinska Institutet, Stockholm, Sweden., Voss G; GlaxoSmithKline Biologicals, Rixensart, Belgium., Heeney JL; Department of Veterinary Medicine, University of Cambridge, UK.; Department of Virology, Biomedical Primate Research Center (BPRC), 2288 GH Rijswijk, The Netherlands.

Publikováno v: The Journal of general virology [J Gen Virol] 2008 Feb; Vol. 89 (Pt 2), pp. 540-5533.

Investigation of the covalent modification of the catalytic triad of human cytomegalovirus protease by pseudo-reversible beta-lactam inhibitors and a peptide chloromethylketone.

Autor: Haley TM; Glaxo Wellcome Research & Development, Medicines Research Centre, Stevenage, Hertfordshire, UK. tmh0149@ggr.co.uk, Angier SJ, Borthwick AD, Montgomery DS, Purvis IJ, Smart DH, Bessant C, Van Wely C, Hart GJ

Publikováno v: Journal of mass spectrometry : JMS [J Mass Spectrom] 1998 Dec; Vol. 33 (12), pp. 1246-55.

A single-pot synthesis of 4-hydroxybenzophenones via acid-catalyzed alkoxylation of p-quinone methides followed by DDQ-assisted oxo-demethoxylation.

Autor: Mahey, Jasbir Kaur, Pawara, Chunilal B., Kamble, Sumit B.

Publikováno v: New Journal of Chemistry; 10/21/2023, Vol. 47 Issue 39, p18419-18429, 11p

Pre-eclampsia in pregnancies resulting from oocyte donation, natural conception or IVF: a systematic review and meta-analysis.

Autor: Keukens, A, Wely, M van, Meulen, C van der, Mochtar, M H, van Wely, M, van der Meulen, C

Publikováno v: Human Reproduction; Mar2022, Vol. 37 Issue 3, p586-599, 14p